Other Existing Shareholders (Israeli)

A group of prominent Israeli institutional investors who have invested in Israeli tech companies.

Institutional Tel Aviv, Israel
Last updated 2026-11-04
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$70.0M
total disclosed, rounds participated
Stages
Seed, Series A, Series B, Growth

About

This entity represents a collective of Israeli institutional investors, including Alpha Opportunities Fund, Harel Insurance, Phoenix Insurance Company, More Investment House, Noked Capital, Arkin Capital, Migdal Insurance, and Yelin Lapidot. They are significant shareholders in various Israeli tech companies, such as Stark Power, and actively participate in funding rounds to support growth and expansion.

Portfolio · 1

Q&A

What is the primary focus of Other Existing Shareholders (Israeli)?
Other Existing Shareholders (Israeli) represents a collective of Israeli institutional investors focused on investing in Israeli tech companies, particularly in sectors like Energy Tech.
Which types of companies does Other Existing Shareholders (Israeli) typically invest in?
Other Existing Shareholders (Israeli) invests in Israeli tech companies across various stages, including Seed, Series A, Series B, and Growth rounds.
Can you name some of the institutional investors that comprise Other Existing Shareholders (Israeli)?
The collective includes prominent Israeli institutional investors such as Alpha Opportunities Fund and Harel Insurance
In which geographies does Other Existing Shareholders (Israeli) prefer to invest?
Other Existing Shareholders (Israeli) primarily focuses its investments in Israel and the US.
What is a notable portfolio company for Other Existing Shareholders (Israeli)?
A notable portfolio company for Other Existing Shareholders (Israeli) is Stark Power.
What sectors are preferred by Other Existing Shareholders (Israeli)?
Other Existing Shareholders (Israeli) prefers sectors such as Energy Tech, Business Software, Fintech & Insurtech, and Health Tech & Life Sciences.